Author

EonJu Jeon

Observed names: Eon Ju Jeon, Eonju Jeon

Institutions: Daegu Catholic University, Daegu Catholic University Medical Center

Observed institutions: Daegu Catholic University, Daegu Catholic University Medical Center

ORCID: 0000-0002-8858-5343

Observed ORCID: 0000-0002-8858-5343

OpenAlex ID: A5055564358

The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea

2020 · Mi Kyung Kim, Jae-Han Jeon, et al. · Diabetes & Metabolism Journal · 104

A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol

2021 · Eun Kyung Lee, Yea Eun Kang, et al. · Endocrinology and Metabolism · 25

Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study

2020 · Jun Sung Moon, Sunghwan Suh, et al. · Diabetes & Metabolism Journal · 19

Optimising the Therapeutic Window: A Systematic Review and Network Meta‐Analysis of Pregabalin Dosing Strategies for Painful Diabetic Neuropathy

2026 · Doyun Kwon, Hee‐Jae Jung, et al. · Diabetes Obesity and Metabolism · 1

Efficacy and Safety of Fixed‐Dose Combinations of Sitagliptin and Empagliflozin as Add‐On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double‐Blind, Multi‐Centre, Placebo‐Controlled, Phase III Trial

2026 · Soo Lim, Tae Nyun Kim, et al. · Diabetes Obesity and Metabolism · 1

Author response for "Optimising the Therapeutic Window: A Systematic Review and Network Meta-Analysis of Pregabalin Dosing Strategies for Painful Diabetic Neuropathy"

2026 · Doyun Kwon, Hee‐Jae Jung, et al. · Publons reviews and discussion

Author response for "Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-on to Metformin in Korean Patients with Type 2 Diabetes: A Randomized, Double-blind, Multi-center, Placebo-controlled, Phase III Trial"

2026 · Soo Lim, Tae Nyun Kim, et al. · Publons reviews and discussion

Author response for "Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-on to Metformin in Korean Patients with Type 2 Diabetes: A Randomized, Double-blind, Multi-center, Placebo-controlled, Phase III Trial"

2026 · Soo Lim, Tae Nyun Kim, et al. · Publons reviews and discussion

Author response for "Efficacy and Safety of Combining Empagliflozin in People with Type 2 Diabetes Mellitus Uncontrolled with Metformin and Sitagliptin: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase 3 Clinical Trial"

2025 · Seung‐Hwan Lee, Kyung Ah Han, et al. · Publons reviews and discussion

A novel RET mutation presented with VHL-like clinical manifestation

2016 · Euidal Jung, EonJu Jeon · Endocrine Abstracts

Works count: 10

Citation count: 150

H-index: 3

I10-index: 3